Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical – FDA Inspection, Mar 23, 2017

Record Details

This FDA Inspection record concerns Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical, with an inspection on March 23, 2017, issued by the Los Angeles District Office, covering human drugs.

Company: Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical
Inspection Date: March 23, 2017
Product Type: Human Drugs
Office: Los Angeles District Office
People: Linda F. Murphy (FDA Associated Person)
Marcellinus D. Dordunoo (FDA Associated Person)
Taichun Qin (FDA Associated Person)

View Company Profile

ID · 10129396-8bbb-472f-9f5e-f760a84ffe55

Inspection Facts

Inspection number: 1005977
FDA center: Human Drugs
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

FDA Inspection

Fusion IV Pharmaceuticals, Inc. dba Axia PharmaceuticalMarch 23, 2017

Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical – FDA Inspection, Mar 23, 2017

Record Details

This FDA Inspection record concerns Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical, with an inspection on March 23, 2017, issued by the Los Angeles District Office, covering human drugs.